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Digital transcript subtraction (DTS) was developed to subtract in silico known human sequences from
expression library data sets, leaving candidate nonhuman sequences for further analysis. This approach
requires precise discrimination between human and nonhuman cDNA sequences. Database comparisons show
high likelihood that small viral sequences can be successfully distinguished from human sequences. DTS
analysis of 9,026 20-bp tags from an expression library of BCBL-1 cells infected with Kaposi’s sarcoma-
associated herpesvirus (KSHV) resolved all but three candidate sequences. Two of these sequences belonged
to KSHV transcripts, and the third belonged to an unannotated human expression sequence tag. Overall,
0.24% of transcripts from this cell line were of viral origin. DTS analysis of 241,122 expression tags from three
squamous cell conjunctival carcinomas revealed that only 21 sequences did not align with sequences from
human databases. All 21 candidates amplify human transcripts and have secondary evidence for being of
human origin. This analysis shows that it is unlikely that distinguishable viral transcripts are present in
conjunctival carcinomas at 20 transcripts per million or higher, which is the equivalent of approximately 4
transcripts per cell. DTS is a simple screening method to discover novel viral nucleic acids. It provides, for the
first time, quantitative evidence against some classes of viral etiology when no viral transcripts are found,
thereby reducing the uncertainty involved in new pathogen discovery.
Although infection contributes to over 20% of human can-
cers worldwide, the list of confirmed carcinogenic infectious
agents is surprisingly short (26). Epidemiologic studies strongly
suggest that novel infectious agents remain to be discovered
and contribute to a broad range of diseases, including cancers,
autoimmune disorders, and degenerative diseases. A major
problem for new pathogen discovery, however, is that when a
search fails to identify an infection, it is not possible to know
whether the search failed because of technical reasons or be-
cause the disease is actually noninfectious and no unique agent
is present. Complicating this issue, infection may be transient
(hit and run) or, in the case of autoimmune diseases, distant
from the site of disease.
This problem is illustrated by the search for human tumor
viruses. Tumorigenic infectious agents have been classified into
two broad categories (27): indirect carcinogens, which lead to
tumorigenesis through chronic infection and nonspecific in-
flammation, and direct carcinogens, agents that express intra-
cellular oncogenes that directly contribute to cell transforma-
tion. Indirect agents, such as Helicobacter pylori and possibly
the hepatitis viruses, can ultimately be lost from the tumor
mass. Direct carcinogens, such as papillomaviruses, Epstein-
Barr virus, and Kaposi’s sarcoma-associated virus (KSHV), are
present in the tumor mass with at least one genome copy per
cell and express a foreign oncogene transcript.
Indirect and direct infectious carcinogens have distinct epi-
demiologic properties. For example, immunosuppression may
lessen the risk of indirect carcinogenesis by reducing chronic
inflammation. In contrast, immunosuppression dramatically
increases the risk of direct carcinogenic tumors by reducing
host immune surveillance. Thus, patterns of disease occur-
rence may give clues as to which types of tumors are most likely
to have a direct or indirect infectious carcinogenic trigger.
A tumor that has long been suspected of having a direct
infectious origin is squamous cell conjunctival carcinoma
(SCCC). SCCC is typically a low-grade malignancy with little
potential for invasion and metastasis (34). This cancer is un-
common in the United States and is primarily a disease of the
elderly (20). There has been, however, a sharp increase in the
incidence of SCCC among patients infected with human im-
munodeficiency virus (HIV) (4, 14, 28, 40), as well as others
with immunodeficiency, such as transplant recipients (17, 33).
SCCC has emerged along with the AIDS epidemic as a very
common cancer in Uganda and parts of sub-Saharan Africa
over the past two decades (18, 21, 41, 44). The striking asso-
ciation of SCCC with HIV infection and its geographic local-
ization in regions of Africa are consistent with a direct carci-
nogenic infectious etiology. Papillomaviruses are a leading
candidate for causing this tumor, but current evidence for their
role in this disease is contradictory. Some investigators have
found an excess occurrence of cutaneous papillomavirus types
in SCCCs by PCR (3, 35). Others have failed to find consistent
evidence of papillomavirus infection by serology (24, 42) and
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by papillomavirus consensus PCR (Y. Chang, unpublished re-
sults) using primers HVP2/B5, CN1F/R, CP62/69, and
EN1F/R (16) and GPb-Gp5/6 (19). We also failed to find
evidence for the presence of adenovirus, herpesvirus, or poly-
omavirus DNA in SCCCs by consensus PCR.
Molecular methods to discover new pathogens can also be
divided into two broad categories (13, 29). One approach uses
sequence information from known pathogens to identify re-
lated but undiscovered agents through cross amplification
(consensus PCR) (25, 37) or cross hybridization (microarray
hybridization) (36). Other approaches do not make assump-
tions about sequence homology for the agent. These tech-
niques include cDNA library panning, used previously to dis-
cover hepatitis C virus (8), and representational difference
analysis, used to discover KSHV (7).
Although each of these methods has been successful in iden-
tifying human viruses, current pathogen discovery approaches
suffer from several shortcomings. None are quantitative, so if
no candidate sequence is found, it is not possible to estimate
how likely it is that an agent is present but missed in the search.
Some approaches, such as representational difference analysis,
rely on isogenic control samples that differ only in the presence
or absence of agent nucleic acids. Since tumors may arise from
rare cell populations, identifying an appropriate comparison
control tissue may be difficult. Finally, there are no simple ways
to scale up pathogen discovery with these methods short of
analyzing additional samples.
It is unlikely that any technique can universally identify all
human viral pathogens. But with the near completion of the
human genome project, high-throughput sequencing may be
exploited to examine specific classes of disease, such as direct
infectious tumors. In theory, it should be possible to distinguish
viral from human transcripts if sufficient sequence length is
available. Longer sequences will increase the specificity of
screening but at the cost of reduced transcriptome sampling
for any given sequencing project. Further, sequences should be
vetted for accuracy since sequencing errors will prevent align-
ment with deposited human sequences and a missequenced
human nucleic acid may be wrongly described as nonhuman.
We have investigated long serial analysis of gene expression
(L-SAGE) as a means to sample cellular transcriptomes for the
presence of viral transcripts. L-SAGE quantitatively concate-
nates 21-bp cDNA tags from the 3 ends of mRNA tran-
scripts, allowing the measurement of gene expression via high-
throughput sequencing (32). If sufficiently stringent conditions
are placed on L-SAGE sequencing accuracy, this should be a
valuable method for rapidly searching for exogenous viral
mRNAs. For a typical L-SAGE tag, there is a high level of
confidence for the first 20 of 21 bp. Variations at the 21st bp
position result from lax type II enzyme site cutting, leading to
uncertainty in base pair assignment during ditag generation
(47).
We have evaluated a novel approach to search for exoge-
nous viral transcripts by using L-SAGE libraries, digital tran-
script subtraction (DTS). Physical transcriptome subtraction to
identify differential or novel transcripts has been described
previously (23). In addition, the direct examination of ex-
pressed-sequence-tag (EST) libraries has been proposed as a
means to identify human pathogens (45, 46). Our approach
differs in that we performed in silico subtraction by the align-
ment of short sequence tags with deposited human sequence
data. Allowing a 1-in-20-base misalignment, we achieved com-
plete in silico human transcriptome subtraction from a KSHV-
infected cell line library, leaving candidate sequences belong-
ing to KSHV. Performing the same analysis on a large
L-SAGE library from three SCCCs, we identified 21 candidate
sequences, all of which have experimental evidence for being
polymorphic human sequences. These results show that DTS
can screen human expression sequence data to identify se-
quences most likely to be of viral origin. DTS shows promise
for rapidly identifying some types of new human tumor viruses
and, when no viral transcripts are found, can establish quanti-
tative limits on the presence or absence of exogenous mRNA.
MATERIALS AND METHODS
Cell culture. Cells of the BCBL-1 line (primary effusion lymphoma [PEL]-
derived B-cell line infected with KSHV) (30) were maintained in RPMI 1640
medium (Cellgro, Herndon, VA) supplemented with 10% fetal bovine serum
(GIBCO, Grand Island, NY) containing penicillin-streptomycin (100 U/ml) and
L-glutamine (2 mM) at 37°C in the presence of 5% CO2.
Clinical samples and RNA preparation. SCCC tissues were obtained from a
large case-control study (involving more than 800 cases) by the Uganda Eye
Project (43). Tissues were made anonymous with respect to patient identifiers
and assigned accession numbers prior to analysis. After surgical extraction,
specimens were stored under liquid nitrogen or in RNAlater solution (Ambion
Inc., Austin, TX) until processed for RNA extraction. Prior to L-SAGE, cryostat-
processed frozen sections of tissues were examined to identify uniform tumor
tissues to be used for RNA extraction. Three SCCCs were included in this study:
(i) tumor tissue from an HIV-negative female (patient 448), (ii) tumor tissue
from an HIV-positive male (patient 1811), and (iii) tumor tissue from an HIV-
positive female (patient 1795). The tumor from patient 448 (tumor 448) was
snap-frozen after surgery, whereas tumors 1811 and 1795 were placed in RNA-
later (Ambion) immediately after surgery. These patients were negative for
human papillomavirus types 16 and 18 in previous serological studies (24).
Total RNA from unstimulated BCBL-1 cells was extracted by TRIzol reagent
(Invitrogen) according to the manufacturer’s instructions. Total RNA from
SCCC tissues was extracted after homogenization with the RNeasy midi kit
(QIAGEN, Alameda, CA). RNAs were assayed for integrity using the Agilent
2100 bioanalyzer (Quantum Analytics, Foster City, CA) with the RNA 6000
Nano reagent kit. Tumor 448 showed marked degradation (an RNA integrity
number of 2), while tumors 1811 and 1795 had high integrity scores (RNA
integrity numbers of 8.2 and 7.5, respectively).
L-SAGE. Four L-SAGE libraries were generated from RNAs from BCBL-1
cells and from the three SCCCs by using the I-SAGE kit according to the
instructions of the manufacturer (Invitrogen, Carlsbad, CA). Library 1811 was
spiked with BCBL-1 RNA prior to L-SAGE to serve as an internal control for
our ability to detect viral sequences in the tumor library. In brief, poly(A) RNA
was captured onto magnetic beads and converted into double-stranded cDNA.
The cDNA was cleaved with NlaIII and then ligated to oligonucleotide adapters
containing recognition sites for MmeI. The linked cDNA was then released from
magnetic beads by digestion with MmeI. Released tags were ligated to each other
to create ditags and amplified by PCR. Amplified ditags were subsequently
concatenated and cloned into the SphI site of pZero-1. Agar lawns were sent for
sequencing of the inserts with the M13 forward primer to either the University
of Pittsburgh Core Sequencing Facility (Pittsburgh, PA) or Agencourt Bio-
sciences Corporation (Beverly, MA).
DTS. All sequences were trimmed at a phred score of 20 (12), a stringent
measure of base-calling accuracy for automated sequencer traces. Tags were
extracted from 32- to 38-bp ditags using the SAGE2000 4.5 analysis software
(Invitrogen) (39) and analyzed with UNIX Perl scripts (available on request) on
a Mac Pro desktop computer. For SCCC DTS analysis, L-SAGE data from the
three separate tumors were combined into a single data set. SAGE tag data files
used in this analysis are available at http://www.kshv.pitt.edu/.
To reduce sequencing errors, the following criteria were used to generate
high-fidelity (HiFi) sequences: tags with ambiguous base calls were eliminated,
and only tags identified independently two or more times were included. After
performing DTS, tags that were not subtracted were examined for linker se-
quences and missequencing errors on electropherograms. These tags were elim-
inated post hoc from the candidate sequences after initial alignment with se-
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quences from reference databases. To generate the HiFi sequences, each unique
sequence from HiFi tags was placed into a text file regardless of the frequency of
occurrence. Since DTS does not rely on gene expression levels once a tag has
been verified, highly abundant and infrequent tags have equal weights in the
analysis.
HiFi sequences were examined using stand-alone BLAST (BLAST-2.2.14-
univeral-macosx at ftp://ftp.ncbi.nih.gov/BLAST/excutables) against multiple nu-
cleotide databases. The detailed information for BLAST parameters can be
viewed at the NCBI website (http://www.ncbi.nlm.nih.gov/staff/tao/URLAPI
/blastall/blastall_node23.html). The following parameter set was used to identify
exact matches among sequences from human RefSeq RNA and genome data-
bases: r  1 (matched reward), q  3 (mismatch penalty), F  F (no filtering
of input sequence), W  20 (word size), and e  10,000 (expectation cutoff). For
the lower-level-homology alignment, the same databases were searched for short,
near-exact matches with the following parameters for cross-species sequence
exploration (22): (r  1, q  1, G  1 [gap opening cost], E  2 [gap extension
cost], F  F, W  7, and e  10,000) and (r  5, q  4, G  25, E  10, F 
F, W  7, and e  10,000). Comparison of candidate sequences to sequences in
viral nonredundant (NR), human NR, and human EST databases was performed
manually using the NCBI website (http://www.ncbi.nlm.nih.gov/BLAST/) and the
following parameter set for short, near-exact matches: r  5, q  4, G  25,
E  10, F  F, W  7, and e  10,000. To ensure that NR and EST sequences
aligning to candidate tags were not nonhuman sequences inadvertently deposited
into the databases, MegaBLAST was used to track aligning sequences back to the
human genome (45).
Sequential database comparisons of the HiFi sequences were performed using
the human RefSeq RNA database first and then the human RefSeq genome
database (http://www.ncbi.nlm.nih.gov/RefSeq/). The latter database includes
human mitochondrial sequences. Further analysis was performed by comparing
sequences to viral NR, human NR, and human EST database entries. All data-
bases were downloaded between September and November 2006 from NIH
NCBI (ftp://ftp.ncbi.nih.gov/BLAST/db).
Virtual herpesvirus expression sequence tag analysis. Genomic sequences of
the human herpesviruses (HHV), including HHV-1 (NC_001806), HHV-2
(NC_001798), HHV-3 (NC_001348), HHV-4 (NC_007605), HHV-5 (NC_001347),
HHV-6 (NC_001664), HHV-6B (NC_000898), HHV-7 (NC_001716), and HHV-8
(NC_003409), were downloaded from GenBank (NCBI). Virtual SAGE tags with
the NlaIII CATG recognition sequence were extracted with Perl scripts. The
pool of virtual herpesvirus tags included all sites with CATG sequences in both
coding and noncoding regions. To examine KSHV gene expression in BCBL-1
experiments, 80 open reading frames (ORFs) from the deposited KSHV se-
quence (KSU75698) (31) were analyzed for NlaIII sites by using MacVector
(Accelrys Inc.) to retrieve the 20-mer tag most proximal to the 3 end of the
transcript.
Reverse transcription-PCR. Candidate sequences from BCBL-1 and SCCC
SAGE libraries were used with rapid amplification of cDNA ends (RACE) or
reverse SAGE (rSAGE) to obtain 3 sequences. Conventional RACE was per-
formed with BCBL-1 cells and two SCCCs, those from patients 1811 and 1795,
by using the 3 RACE system according to the instructions of the manufacturer
(Invitrogen). rSAGE followed the protocol of Jian Yu (University of Pittsburgh;
http://www.sagenet.org/protocol) to isolate cDNA fragments corresponding to
novel SAGE tags. Briefly, poly(A) RNA from an SCCC from patient 1795 was
used to synthesize double-stranded cDNA with a specifically designed biotin-
labeled primer, BRS1, containing an AscI restriction enzyme site. The cDNA was
digested with NlaIII and then bound to streptavidin beads. This complex was
then bound to linker 2A/B and digested with AscI to release the 3 cDNA
fragments from the beads. These 3 cDNA fragments were then enriched by
PCRs to obtain a sufficient quantity of DNA (amplified rSAGE library). A
second PCR amplification was performed with L-SAGE tag-specific primers and
a common M13 forward primer to obtain specific products. PCR products from
both RACE and rSAGE were TA cloned into pCR2.1 vector (Invitrogen), and
the sequencing of the PCR products (at least two colonies) was used to verify the
authenticity of a given L-SAGE tag and to obtain additional nucleotide se-
quences that could be used in database searches.
RESULTS
Virtual analysis of herpesvirus L-SAGE tags. To empirically
determine if L-SAGE tags have sufficient sequence diversity to
distinguish viral from human sequences, we generated a virtual
pool of L-SAGE tags from known HHV genomes (Table 1).
The 9,484 virtual NlaIII site tags from nine HHV genomes,
representing nearly 1.4 million bp, were aligned with sequences
in the NCBI human RefSeq RNA and RefSeq genome data-
bases. For this analysis, we included all NlaIII sites, not just 3
coding sites, as would occur in experimental SAGE. Only 27
(0.28%) 21-bp and 94 (1.0%) 20-bp virtual herpesvirus SAGE
tags align perfectly with the human genome. Of 80 virtual ORF
tags from the 3 ends of KSHV transcripts, none was found to
match human sequences. Since herpesviruses extensively
pirate host regulatory and DNA synthesis genes (10), this is
likely to be a conservative approximation of sequence similar-
ity for other viruses. Standard L-SAGE analyses assume a
21-bp tag length, but the accuracy of only the first 20 bp can be
assured with a high level of confidence due to variability in
MmeI cutting. As expected, a modest increase in the tag length
from 20 to 21 bases markedly increased alignment specificity.
To identify viral candidates, polymorphic human sequences
TABLE 1. Comparison of virtual HHV tags with human RefSeq database entries to assess the degree of divergence
between human and viral sequencesa
Virus
Size (bp) of
whole genome
No. of virtual
tags
No. of tags matching RefSeq sequence over: No. (%) of
remaining 19-
of-20-base tags21 of 21 bases 20 of 20 bases 19 of 20 bases
HHV-1 152,261 842 1 4 112 730 (86.70)
HHV-2 154,746 786 2 4 84 702 (89.31)
HHV-3 124,884 891 0 5 255 636 (71.38)
HHV-4 171,823 1,242 4 15 356 886 (71.34)
HHV-5 230,287 1,624 1 15 286 1,338 (82.39)
HHV-6 159,321 1,027 4 11 320 707 (68.84)
HHV-6B 162,114 1,076 6 16 338 738 (68.59)
HHV-7 153,080 941 6 17 425 516 (54.83)
HHV-8/KSHV 137,508 1,055 3 7 243 812 (76.97)
Total 1,446,024 9,484 27 94 2,419 7,065 (74.49)
KSHVb 80 0 0 16 64 (80)
a Virtual tags were extracted from nine herpesviruses and compared by BLAST search against human RefSeq sequences by using perfect-match (21-of-21- and
20-of-20-base) and one-mismatch (19-of-20-base) criteria. Virtual tags represent all NlaIII sites rather than actual 3 cDNA SAGE tag sites to increase viral genome
sampling in this comparison. The numbers and percentages of remaining tags were calculated with the cutoff of one mismatch in 20-bp tags.
b Actual L-SAGE tag sequences in KSHV coding regions.
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with near-exact alignment with reference database sequences
must be excluded. Allowing for mismatches, however, in-
creases the likelihood that true viral sequences will be mis-
taken for human. Allowing for a 1-in-20-base mismatch results
in alignments for 2,419, or 25.5%, of 20-bp herpesvirus tags
with human sequences. If three viral transcripts are present,
the likelihood that all three tags will be misidentified as human
drops to 1.66% ([0.255]3). This calculation suggests that it is
practical to use a 1-in-20 mismatch alignment to screen for
viral sequences in human expression libraries.
DTS analysis of PEL. We next sought to determine if a
known tumor virus can be identified de novo using in silico
subtraction and to determine the abundance of viral tran-
scripts. KSHV was discovered in 1993 (7) using a physical
subtraction process, representational difference analysis, that
first isolated two small viral DNA fragments but allowed sub-
sequent full characterization of the virus (31). To determine if
DTS can achieve similar results, we performed L-SAGE with
the PEL cell line BCBL-1 (30), which is latently infected with
approximately 30 viral genome copies per cell. A total of 9,026
tags from the BCBL-1 L-SAGE library were sequenced
(Table 2).
Since missequenced or misextracted tags may be falsely
identified as nonhuman, we reduced the SAGE data set to a
smaller, HiFi data set composed of unique sequences. This
reduction was achieved by extracting sequences with a phred
score of 20, eliminating tags with one or more ambiguous base
calls. We then compiled unique sequences from tags indepen-
dently sequenced two or more times. To account for variation
in MmeI cutting (47), tag lengths were initially restricted to 20
bp, although longer tag lengths can be confirmed by manually
inspecting smaller groups of ditags. This approach generated a
HiFi data set of 994 sequences representing 5,136, or 56.90%
(5,136 of 9,026), of the original BCBL-1 L-SAGE tags.
Sequential DTS database comparisons (Fig. 1) of the 994
HiFi sequences eliminated all but 34 sequences as having exact
20-of-20-bp alignment with deposited human sequences. An
additional 31 sequences diverged from the human database
sequences at 1 of 20 bp, leaving 3 candidate sequences repre-
TABLE 2. Frequencies of tags in the L-SAGE librariesa
No. of
occurrences
and/or
description
No. of tags with unique sequences (total no. of tags)
in library generated from:
BCBL-1 cells
Tumor 1811
spiked with
BCBL-1 RNA
Combined 1811,
1795 and 448
SCCC data sets
74 2 (198) 18 (4,124) 268 (73,198)
25–74 31 (1,259) 59 (2,473) 648 (25,517)
5–24 204 (1,828) 527 (4,794) 4,945 (46,089)
2–4 757 (1,851) 1,984 (4,925) 12,343 (30,926)
2 (HiFi) 994 (5,136) 2,588 (16,316) 18,204 (175,730)
1 3,688 (3,688) 7,351 (7,351) 61,878 (61,878)
Unambiguous 4,682 (8,824) 9,939 (23,667) 80,082 (237,608)
Total (9,026) (23,700) (241,122)
a The total pool of tags was analyzed for tag frequency. Data in italics corre-
spond to the tags identified more than once in the SAGE libraries, which were
used as HiFi sequences for DTS analysis.
FIG. 1. Schematic diagram for in silico subtraction of BCBL-1 L-SAGE tags. L-SAGE was performed on BCBL-1 cell line RNA to generate
9,026 20-bp tags. HiFi sequences from two or more tags were chosen after the exclusion of ambiguous tags and single-reading tags from the total
group of tags. HiFi sequences were then compared against human RefSeq database (RNA and genomic) entries downloaded from the NCBI
website for exact and near-exact (19-in-20-base) matches. The identities of KSHV T1.1 and K12 sequences were confirmed by 3 RACE. Hum,
human.
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sented by 19 tags (0.21%) for analysis. Two of these three
sequences exactly map to transcripts of the KSHV genome
(gi:2065526) T1.1 locus (nucleotides 29640 to 29659; 11 tags)
and K12 locus (nucleotides 117460 to 117441; 6 tags), previ-
ously described as being present in BCBL-1 cells (48). These
viral transcripts are highly abundant, accounting for 1,219 and
665 transcripts per million (TPM), respectively, in the BCBL-1
library. The viral origin of these sequences was confirmed by
experimental 3 RACE with product sequencing (data not
shown). The third candidate sequence precisely matches an
unannotated human EST (gi:78486988; two tags). Reanalysis
of the entire 8,824-tag library for KSHV-specific transcript tags
identified five additional KSHV tags sequenced once, and
therefore not included in our HiFi data set, for KSHV genes
ORFK2 (encoding viral interleukin-6), ORFK13 (encoding v-
FLIP), ORF58, ORF64, and ORF38. Taken together, KSHV
transcripts constituted 0.24% [(11  6  1  1  1  1 
1)/9,026] of the total transcriptome from this uniformly virus-
infected cancer cell line. These results indicate that complete
in silico subtraction of HiFi human L-SAGE tags using DTS is
feasible.
DTS analysis of SCCC. We next extracted mRNA from
three SCCCs, tumors 1811 (AIDS associated), 1795 (AIDS
associated), and 448 (non-AIDS associated), for L-SAGE li-
brary generation. Tumor tissues were dissected prior to extrac-
tion to reduce the contamination of healthy-tissue RNA. L-
SAGE libraries were separately generated and sequenced, and
then tag data from the three libraries were combined for DTS
analysis. To validate DTS, BCBL-1 RNA was spiked (1:20)
into one tumor (1811) prior to L-SAGE. KSHV RNA was
absent from this tumor prior to spiking by PCR (data not
shown). BCBL-1 RNA spiking prevents accurate gene expres-
sion determination for this library but should not affect DTS,
which relies only on sequence occurrence, not tag frequency.
L-SAGE data from tumors 1811 (23,700 tags), 1795 (137,224
tags), and 448 (80,198 tags) were combined to generate an
SCCC library pool containing 241,122 L-SAGE tags from the
three tumors (Table 2). Of these 241,122 SAGE tags, 175,730
(72.88%) met our criteria for HiFi, forming a HiFi data set of
18,204 different 20-bp sequences to be used in DTS.
The SCCC HiFi sequences were subtracted as shown in
Fig. 2. Exact alignments to human RefSeq RNA and RefSeq
genome sequences were found for all but 1,120 SCCC HiFi
sequences. By allowing one mismatch, an additional 974
HiFi sequences aligned with RefSeq database entries, leav-
ing 146 candidate sequences for analysis. To reduce the
candidate pool to a high-likelihood data set, the 146 candi-
date sequences were compared to the sequences in the hu-
man NR and EST databases. This step subtracts unanno-
tated and polymorphic tag sequences but also may subtract
viral sequences that have been inadvertently deposited into
these databases. To avoid this problem, all NR and EST
sequences matching the candidate sequences were com-
pared with sequences in the RefSeq databases by using
MegaBLAST to allow mapping back to human chromo-
somes. Of the 146 candidate sequences, 96 aligned with NR
FIG. 2. In silico subtraction analysis of SCCC transcriptome. Three separate L-SAGE libraries were generated from SCCCs (two AIDS
associated and one non-AIDS associated), resulting in a combined 241,122-SAGE-tag pool and 18,204 unique HiFi sequences. Sequential
subtraction generated 146 sequences that were compared to EST and NR database entries to generate a candidate list of 21 HiFi sequences. These
21 sequences were examined by rSAGE and 3 RACE for evidence of human origin. Hum, human.
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and EST sequences, and the majority of these contained 3
polyadenylation tracts that were not included in RefSeq
database sequences. The remaining group of 50 20-base
sequences did not align with human sequences at 19 or more
bases. Of these 50 sequences, manual analysis revealed that
24 arose artifactually from duplicated ditags and 2 contained
sequencing errors found by the inspection of electrophero-
grams. These 26 sequences were eliminated from the HiFi
data set, leaving 24 candidate sequences.
Of the 24 remaining sequences, 2 were SAGE linker se-
quences and 1 sequence, represented by three SAGE tags
found exclusively in the spiked 1811 library, corresponded to
the KSHV T1.1 sequence previously identified in the BCBL-1
experiments. This sequence was again confirmed by experi-
mental 3 RACE (data not shown). The abundance of this tag
was 127 TPM (3 of 23,700 tags in the 1811 library), which is not
significantly higher than predicted (61 TPM; chi-square
value  0.58). Thus, 21 sequences were identified as candidate
viral transcript sequences by DTS.
Analysis of SCCC DTS candidate sequences. The 21 non-
aligning sequences (Table 3) remaining after DTS screening
were used for reverse transcription. rSAGE and 3 RACE
products from all 21 sequences were cloned and sequenced,
and all products corresponded to human transcript sequences,
evidence that no distinguishable viral transcript sequences
were present in our HiFi data set. Due to potential mispriming
with these short sequences, however, each sequence was ex-
amined in greater detail. Four of the 21 sequences aligned with
immunoglobulin variable-region gene sequences, and two
aligned with highly polymorphic mitochondrial DNA se-
quences. Two additional sequences were deposited from mul-
tiple libraries into the NIH SAGEmap database (http://www
.ncbi.nlm.nih.gov/projects/SAGE/). These eight sequences
were considered likely to be human and excluded from further
analysis (Table 4).
Direct inspection of ditags allowed high-level-confidence
elongation of 12 of the 13 remaining candidate sequences to
21 bases (Table 4). Short-sequence, exact BLAST alignment
with human NR sequences revealed nine of these sequences
to match human sequences at 19 of 21 base pairs, providing
additional evidence for their human origin. For the remain-
ing four sequences, comparison to virus NR database entries
revealed that all but one sequence had lower degrees of
homology to viral than to human sequences. A transcript
belonging to a virus causing SCCC would be expected to be
found independently in more than one SCCC library, but
tags from all four remaining sequences were found in only
one library (1795).
Although these 21 DTS candidates should be considered for
future studies, present evidence suggests that all 21 sequences
are of human origin. If none of the candidate tags belong to
viral transcripts, and assuming a Poisson distribution for se-
quencing a viral transcript, the upper 95% confidence limit
that a viral transcript exceeding our matching criteria is present
in SCCC is 20 TPM. It is estimated that there are approxi-
mately 200,000 mRNA transcripts in a cell, corresponding to 5
TPM for a single mRNA copy per cell (5, 38). Using this value
as a comparison, we sequenced to a level of two to three
transcripts per cell (11 TPM) and can conclude with a 95%
confidence level that DTS-identifiable viral transcripts are not
present in conjunctival carcinoma at four transcripts per cell or
higher (20 TPM).
TABLE 3. Representative results of DNA sequencing of RACE and rSAGE products of 24 HiFi sequences
Tag sequence
No. of
occurrences
GenBank accession no. of
corresponding human
sequence
Description
CATGTCGGACGTACATCGTT 81 Adapter in L-SAGE
CATGTCGGATATTAAGCCTA 22 Adapter in L-SAGE
CATGTTATACTTTTGACAAT 3 U66521 KSHV T1.1 mRNA transcript
CATGCGCTGGGCATCTACCC 7 AB064111 Homo sapiens mRNA for immunoglobulin  light-chain VL-J region
CATGGTAAGTGCACTTGGAC 6 DQ523681 H. sapiens isolate 2798T mitochondrion gene
CATGGTATTACCAACTGGTT 4 BC073764 H. sapiens immunoglobulin  constant gene
CATGCAAAGTTTACAACTTC 2 BC063599 H. sapiens immunoglobulin  variable-region gene sequence
CATGGCCACCTATCACACCC 2 EF060266 H. sapiens isolate Paudibhuiya_84 mitochondrion gene
CATGCAGACTACACAGTGGC 2 BC073791 H. sapiens immunoglobulin  constant gene
CATGGTAGGGGGCTTGAGGA 2 NM_003564 H. sapiens transgelin 2 gene
CATGGATAGCACGCCGCATA 2 NM_002107 H. sapiens H3 histone gene, family 3A
CATGCAGCTGGCAATCAATA 4 NM_000526 H. sapiens keratin 14 gene
CATGGCCCACATTAGAATAA 3 NM_001025158 H. sapiens CD74 molecule gene, major histocompatibility complex
CATGGGGTGTCAATAAAGCT 2 NM_002178 H. sapiens insulin-like growth factor binding protein 6 gene
CATGGGATAGGTGGGGCGGG 2 NM_032818 H. sapiens chromosome 9 ORF100
CATGCAGGTTTCACATTCTA 2 NM_004887 H. sapiens chemokine (C-X-C motif) ligand 14 gene
CATGGACCTGAATTGCCTGG 2 AK123483 H. sapiens cDNA FLJ41489 fis
CATGTAATATTATCCTGTCC 2 NM_144691 H. sapiens calpain 12 gene
CATGGAGATTGCCCCTGCTG 2 NM_006142 H. sapiens stratifin gene
CATGTATGCTGGTTCCACCA 2 AL161669 Human chromosome 14 DNA sequence BAC R-736N17 of library
RPCI-11 from chromosome 14
CATGTTGGACGTACATCGTT 2 NM_002213 H. sapiens 5 integrin gene
CATGCAGCTGGACCCTGCTT 3 NM_000526 H. sapiens keratin 14 gene
CATGTCGGACGTACACGTTA 3 AL034344 Human DNA sequence from clone RP1-118B18 on chromosome
6p24.1-25.3
CATGCCGACGATGCCCAGAA 2 NM_022873 H. sapiens alpha interferon-inducible protein 6 gene
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DISCUSSION
Short human expression tags can be reliably subtracted to
screen for exogenous viral transcript sequences, opening the
possibility of using high-throughput sequencing to discover
new viral pathogens. L-SAGE is attractive for DTS since it
uses polyadenylated mRNA and will not include most bacterial
RNAs found in nonsterile-site tissues such as conjunctival tu-
mors. DTS can be applied to other expression sampling tech-
niques, such as massively parallel sequencing, and will improve
with tags longer than those in this study. DTS differs from
standard SAGE in that only HiFi sequence data are used and
comparison can be made without control tissue samples. Once
a tag sequence is accepted as valid, tag frequency is not taken
into account.
Our analysis suggests that 20 bases is the minimum useful
length for DTS. Early attempts to perform DTS with 14-base
SAGE tags failed to discriminate between human and viral
sequences (Y. Chang and P. S. Moore, unpublished results). At
shallow sequencing depths as used for the BCBL-1 library,
20-bp DTS readily identified viral sequences and allowed com-
plete transcriptome subtraction. When more extensive se-
quencing is performed, as seen with our SCCC library, the
numbers of ambiguous and rare tag sequences increase, gen-
erating a large list of candidates (146) that require further
subtraction using NR and EST library databases and manual
inspection. We anticipate that even small increases in tag
lengths should be able to markedly reduce the candidate pool
size, as well as increase the discrimination between viral and
human sequences.
Another important advantage in using SAGE or other quan-
titative expression profiling techniques for DTS is that a direct
measurement of transcript levels can also be performed. This
capacity is shown by our analysis of viral transcripts in a tumor
virus-infected cell line (BCBL-1). KSHV transcripts constitute
a high percentage (0.24%) of the total mRNA from BCBL-1
cells. Transcripts identified in PEL cells are identical to those
TABLE 4. Virtual analysis of 21 candidates with one extra base
Tag sequence Sequence with extra basea
Aligns with
immunoglobulin
or mitochondrion
sequence
Present in
SAGEmap
database
(no. of
libraries)
No. of matching bases/
no. of bases analyzed
relative to: Accession no. and description of best-
match virus or viral gene or regionBest-match
human NR
sequence
Best-match
viral NR
sequence
CATGCGCTGGGCATCTACCC CATGCGCTGGGCATCTACCCg Yes 19/21 18/21 AB154196.1, hepatitis C virus type 1b
polyprotein gene
CATGGTAAGTGCACTTGGAC CATGGTAAGTGCACTTGGACg Yes Yes (13) 18/21 17/21 DQ279927.1, human herpesvirus 4 strain
AG876
CATGGTATTACCAACTGGTT CATGGTATTACCAACTGGTTa Yes 19/21 17/21 AF039490.1, gp41 (env) gene of HIV-2
isolate PO1 clone C1.6 from Portugal
CATGCAAAGTTTACAACTTC CATGCAAAGTTTACAACTTCc Yes 19/21 18/21 U37488.1, human papillomavirus type 54
CATGGCCACCTATCACACCC CATGGCCACCTATCACACCCc Yes 19/21 18/21 AF478169.1, porcine lymphotropic
herpesvirus long unique region
CATGCAGACTACACAGTGGC CATGCAGACTACACAGTGGCc Yes 18/21 17/21 AF331718.1, Alkhurma virus strain 1176
polyprotein gene
CATGGTAGGGGGCTTGAGGA CATGGTAGGGGGCTTGAGGAa Yes (10) 19/21 18/21 AY309060.1, mumps virus isolate
Dg1062/Korea/98
CATGGATAGCACGCCGCATA CATGGATAGCACGCCGCATAc Yes (2) 18/21 18/21 AY864330.1, Chrysodeixis chalcites
nucleopolyhedrovirus
CATGCAGCTGGCAATCAATA CATGCAGCTGGCAATCAATAc Yes(1) 19/21 18/21 AF512031.3, Choristoneura fumiferana
multicapsid nucleopolyhedrovirus
polyhedrin gene
CATGGCCCACATTAGAATAA CATGGCCCACATTAGAATAAa Yes (1) 19/21 18/21 AY355259.1, human rhinovirus 78 VP1
capsid protein gene
CATGGGGTGTCAATAAAGCT CATGGGGTGTCAATAAAGCTg Yes (1) 19/21 17/21 DQ127618.1, Emiliania huxleyi virus 163
clone
CATGGGATAGGTGGGGCGGG CATGGGATAGGTGGGGCGGGa Yes (1) 19/21 18/21 AY564767.1, hepatitis C virus isolate
BO-124 polyprotein gene
CATGCAGGTTTCACATTCTA CATGCAGGTTTCACATTCTAa 19/21 19/21 AF160139.1, coxsackievirus B4 isolate
8033 polyprotein gene
CATGGACCTGAATTGCCTGG CATGGACCTGAATTGCCTGGc 19/21 18/21 AY729654.1, Sudan Ebola virus strain
Gulu
CATGTAATATTATCCTGTCC CATGTAATATTATCCTGTCCc 19/21 18/21 AY552664.1, feline immunodeficiency
virus isolate Ple-349 subtype B
polyprotein (pol) gene
CATGGAGATTGCCCCTGCTG CATGGAGATTGCCCCTGCTGa 19/21 19/21 AY618418.1, maize mosaic virus
CATGTATGCTGGTTCCACCA CATGTATGCTGGTTCCACCAg 19/21 18/21 DQ116961.1, West Nile virus isolate
goshawk-Hungary/04
CATGTTGGACGTACATCGTT CATGTTGGACGTACATCGTTa Yes (1) 18/21 18/21 AJ781163.1, Amasya cherry disease-
associated chrysovirus ORF4
CATGCAGCTGGACCCTGCTT CATGCAGCTGGACCCTGCTT 18/20 17/20 AF333347.1, cetacean morbillivirus
phosphoprotein (P) gene
CATGTCGGACGTACACGTTA CATGTCGGACGTACACGTTAg 17/21 18/21 AF325155.1, Spodoptera litura
nucleopolyhedrovirus strain G2
CATGCCGACGATGCCCAGAA CATGCCGACGATGCCCAGAAt 18/21 18/21 DQ504428.1, Clanis bilineata
nucleopolyhedrosis virus isolate DZ1
a Extra bases are in lowercase.
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previously found by Cornelissen and colleagues using short
SAGE of Kaposi’s sarcoma (KS) tumors (9). T1.1 is commonly
referred to as a lytic gene product, but multiple studies have
shown that it is also readily detected in resting PEL cells.
Whether this is due to transcriptional control outside of the
latent-lytic replication cycle or to a fraction of cells in culture
undergoing lytic replication cannot be addressed by our study.
An examination of unpublished 293 cell line SAGE data from the
Cancer Genome Anatomy Project (293 human embryonic kidney
cells) (6) for 41,955 tags shows similar levels of viral transcript
abundance (0.31%). In contrast to BCBL-1 cells, 293 cells are
artificially transformed with adenovirus DNA rather than natu-
rally infected with a virus (15).
Tumor tissues are likely to have a far lower level of viral
gene expression than cell lines. This is due to lower viral copy
numbers and infiltration by uninfected, nontumor cells. Cor-
nelissen et al. examined two KS tumors from HIV-infected
patients by SAGE and found 24 of 45,913 tags (522 TPM, or
104 transcripts per cell) and 3 of 47,316 tags (63 TPM, or 12
transcripts per cell) belonging to KSHV (9). These levels are
comparable to the transcript abundance found for KSHV (127
TPM) in our library 1811 spiking experiments. We did not
identify a viral transcript after sequencing to a depth of two to
three transcripts per cell (11 TPM), and we can exclude with
95% confidence the possibility that distinguishable viral tran-
scripts are present in SCCC at approximately four transcripts
per cell (20 TPM) or higher—a level far below that found
empirically for KSHV in KS tumors. To confirm these results,
we performed an entirely new long-EST analysis of library
1811, analyzing an additional 150,000 50- to 200-bp ESTs, but
did not identify a candidate viral sequence (H. Feng, Y. Chang,
and P. S. Moore, unpublished results). For technical reasons,
these data cannot be directly added to our current DTS anal-
ysis, but they provide additional confidence in the validity of
the analysis and substantially extend the lower limit for the
detection of a unique viral transcript in SCCCs.
Despite DTS evidence against a direct viral carcinogen’s
being present in SCCC, there are important caveats to con-
cluding that SCCC does not have an infectious etiology. Viral
NlaIII SAGE tags indistinguishable from human transcripts
will be missed by DTS. Our virtual herpesvirus tag analysis
suggests that this would occur for approximately 25% of viral
tags. This uncertainty is reduced if a virus expresses multiple
transcripts. Similarly, if a viral transcript does not contain a
suitable NlaIII site, it will not be processed into a SAGE tag.
Subtraction using unannotated EST transcripts also increases
the probability that a viral sequence previously identified dur-
ing EST screening will falsely be subtracted. We have mini-
mized this risk by mapping all unannotated EST sequences
back to the human genome, but it remains a possible pitfall.
While most RNA viruses and all DNA viruses express mRNA
transcripts, those viruses that do not have polyadenylated tran-
scripts will be missed. Finally, DTS is unlikely to identify en-
dogenous retroviral sequences that have been annotated as
human or retroviruses integrating into the host genome and
acting through insertional mutagenesis (11). These and other
caveats to DTS analysis are listed in Fig. 3 and should be kept
in mind when interpreting DTS results. For these reasons, it
remains possible that SCCC has an infectious etiology, but it is
highly unlikely that this tumor is caused by a direct viral car-
cinogen (e.g., human papillomavirus, Epstein-Barr virus, or
KSHV).
DTS has marked advantages over other existing methods for
new viral pathogen discovery. Physical enrichment of encapsi-
dated viral nucleic acids has been successfully used to identify
new human parvoviruses (2) and polyomaviruses (1) from re-
spiratory secretions. This is unlikely to be useful for tumor
viruses that initiate tumorigenesis during latent infection, in
which the viral episome is not encapsidated. In silico subtrac-
tion, however, shows promise for directly identifying viral se-
quences within the context of the host cell transcriptome. If
DTS is used with a quantitative expression technology like
L-SAGE, it provides estimates of the presence or absence of a
distinguishable viral transcript. For diseases in which the epi-
demiology and biology implicate a detectable exogenous virus,
DTS may prove to be a powerful tool for either identifying or
eliminating a viral etiology.
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